跳至主要内容
临床试验/DRKS00024022
DRKS00024022已完成未知

Prospective randomized Study to Assess the Impact of a Single Dose of a Nutritional Supplement (AlcoDetox) on Alcohol Absorption in Healthy Subjects - PERA-ATX-002

Peradil AB0 个研究点目标入组 24 人开始时间: 2021年1月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Preferably participant of study PERA-ATX-001
  • and/or new participants fulfilling the following criteria:
  • 2. Age > 18 years and = 65 years
  • 3. Caucasian
  • 4. Not suffering from any major disease
  • 5. Willing to perform the two drinking experiments
  • 6. No alcohol consumption within 3 days prior to study participation (negative EtG urine test)
  • 7. Negative Drug Screening test
  • 8. Negative pregnancy test
  • 9. Negative Corona-Test (PCR-Test to be done at study site)

排除标准

  • 1. Acute or chronic disease
  • 2. Present or History of alcohol addiction
  • 3. Known allergy against probiotic nutritional supplements
  • 4. Participation in another clinical trial.
  • 5. Progressive fatal diseases
  • 6. Participants taking medication (including non-prescription drugs)
  • 7. Participants taking other dietary supplements
  • 8. Past or current drug or alcohol abuse
  • 9. Pregnancy or breast feeding
  • 10. Lack of compliance or other similar reason, that, the investigator believes, precludes satisfactory participation in the study

研究者

发起方
Peradil AB

相似试验

Prospective randomized Study to Assess the Impact of... | 临床试验